• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Evolus(EOLS.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Mizuho analyst reiterates buy rating on Evolus
09:42
Evolus released FY2025 9 Months earnings on November 5 After-Market (EST), actual revenue USD 206.88 M, actual EPS USD -0.8053
00:00
Evolus released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 68.97 M (forecast USD 67.42 M), actual EPS USD -0.2431 (forecast USD -0.2675)
00:00
Oct29
Evolus to Release FY2025 Q3 Earnings on November 5 After-Market EST, Forecast Revenue USD 67.42 M, EPS USD -0.2675
00:38
Oct10
Goodman covers healthcare industry and focuses on specific stocks
12:26
Aug25
Evolus Inc announces positive results for Evolysse Sculpt study
12:10

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 68.97 M, Net Income -15.74 M, EPS -0.2431

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 69.39 M, Net Income -17.14 M, EPS -0.2656

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 68.52 M, Net Income -18.89 M, EPS -0.2965

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
10.145
+147.43%
+6.070
ANGH
3.810
+64.22%
+1.480
ESHA
22.060
+53.41%
+7.950
SIDU
3.990
+49.43%
+1.325
NCL
0.2783
+43.45%
+0.084
RDACR
0.2493
+31.21%
+0.059
ESHAR
0.2216
+30.35%
+0.052
LRE
1.650
+27.91%
+0.357
VNDA
8.954
+27.37%
+1.924
ULY
3.475
+25.91%
+0.715
View More